Today: 7 February 2026
Subscribe

Stagwell (STGW) Soars After Q3 Beat and Palantir AI Partnership; 2025 Outlook Calls for ~8% Net Revenue Growth (Nov. 6, 2025)

Stagwell (STGW) Soars After Q3 Beat and Palantir AI Partnership; 2025 Outlook Calls for ~8% Net Revenue Growth (Nov. 6, 2025)

What’s new today Earnings: Stagwell Inc. (NASDAQ: STGW) reported third‑quarter revenue of $743 million, GAAP EPS of $0.09, and adjusted EPS of $0.24. Management highlighted double‑digit “ex‑advocacy” momentum, with net revenue ex‑advocacy up 10% to $578 million, and adjusted EBITDA of $115 million (19% margin on net revenue). The company also pointed to $122 million in net new business for the quarter and a $100 million year‑to‑date improvement in operating cash flow versus last year. PR Newswire Independent wire coverage from the Associated Press echoed the headline figures and noted the full‑year adjusted EPS range of $0.75–$0.88. Times Union Street
6 November 2025
·
Iovance Biotherapeutics (IOVA) Q3 2025: Revenue Climbs ~13% to ~$68M; Gross Margin Hits 43%, Guidance Reaffirmed — November 6, 2025

Iovance Biotherapeutics (IOVA) Q3 2025: Revenue Climbs ~13% to ~$68M; Gross Margin Hits 43%, Guidance Reaffirmed — November 6, 2025

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) reported third‑quarter 2025 results this morning (Nov. 6), highlighting sequential revenue growth, materially higher gross margins, and steady commercial momentum for its tumor‑infiltrating lymphocyte (TIL) therapy Amtagvi. Management also reaffirmed full‑year revenue guidance and flagged pipeline milestones led by encouraging lung‑cancer data for lifileucel. GlobeNewswire What Iovance announced (Nov. 6, 2025) Revenue, margin, and guidance. Total product revenue grew to ~$68M in Q3 (Amtagvi ~$58M; Proleukin ~$10M). Gross margin expanded to 43% on improved execution and early cost‑savings. Management reaffirmed $250–$300M in 2025 revenue. GlobeNewswire Earnings snapshot. An AP/Automated Insights brief noted a net loss
6 November 2025
··
Novavax (NVAX) Raises 2025 Revenue Outlook After Q3 Beat; Sanofi Milestones Drive Guidance — November 6, 2025

Novavax (NVAX) Raises 2025 Revenue Outlook After Q3 Beat; Sanofi Milestones Drive Guidance — November 6, 2025

What happened today Novavax, Inc. (NASDAQ: NVAX) reported Q3 2025 results and raised its full‑year adjusted revenue framework to $1.04–$1.06 billion (from $1.00–$1.05 billion). Management cited momentum from licensing, supply, and milestone revenue—while excluding Sanofi‑led sales and royalties from the outlook. The company also reaffirmed 2025 operating‑expense guidance. ir.novavax.com Revenue for the quarter came in at $70 million, above Wall Street expectations, while the GAAP net loss widened to $202 million year‑over‑year, reflecting $126 million in non‑cash charges, including $97 million related to a previously announced Maryland facility consolidation. Reuters On a per‑share basis, Novavax posted a GAAP loss of
6 November 2025
···
Fortinet (FTNT) slips on soft Q4 outlook after Q3 beat; price targets trimmed as company unveils “Secure AI Data Center” — Nov. 6, 2025

Fortinet (FTNT) slips on soft Q4 outlook after Q3 beat; price targets trimmed as company unveils “Secure AI Data Center” — Nov. 6, 2025

Earnings snapshot: strong quarter, but guidance cools sentiment What happened: Fortinet’s September‑quarter (Q3 FY25) revenue rose ~14% to ~$1.72B with adjusted EPS at $0.74 (vs. ~$0.63 expected). Billings—a forward demand proxy—also climbed ~14% to ~$1.81B. After the report, investors focused on the softer Q4 guide, which ran a touch below consensus and drove the shares lower in late trading. Investors Profitability: Management cited a record Q3 non‑GAAP operating margin of ~36.9% (GAAP operating margin also a third‑quarter record, per the release). That efficiency was a bright spot despite the cautious near‑term revenue view. Investing.com+1 Q4 & FY25 outlook: Fortinet now
6 November 2025
··
AppLovin (APP) soars ~7% after blowout Q3 2025: revenue up 68%, buyback boosted by $3.2B, and Wedbush lifts price target to $800

AppLovin (APP) soars ~7% after blowout Q3 2025: revenue up 68%, buyback boosted by $3.2B, and Wedbush lifts price target to $800

AppLovin Corporation (NASDAQ: APP) is rallying today after reporting another set of blockbuster results and raising its buyback firepower. Shares were up roughly 7%–8% in Thursday trading as investors digested the company’s stronger‑than‑expected Q3 print and upbeat Q4 outlook, while sell‑side analysts raised targets. Barron’s+1 Key takeaways What happened in Q3 (ended Sept. 30, 2025) AppLovin’s top and bottom lines accelerated again in Q3: Management also highlighted $1.05B in operating cash flow and free cash flow during the quarter, underpinned by continued scale in its software and AI solutions for advertisers. Q4 Investor Relations Capital returns: buyback gets much bigger
6 November 2025
·
DoorDash (DASH) plunges as 2026 spending plan eclipses Q3 beat — What to know today (Nov 6, 2025)

DoorDash (DASH) plunges as 2026 spending plan eclipses Q3 beat — What to know today (Nov 6, 2025)

DoorDash, Inc. (NASDAQ: DASH) is under pressure today after the delivery platform beat Q3 revenue and order-growth expectations but told investors it will spend “several hundred million dollars more” in 2026 to accelerate a new global tech platform and other initiatives. Shares fell sharply in after‑hours trading last night and were down again in early trading today as Wall Street digested the outlook. Financial Times+1 By the numbers (Q3 2025, quarter ended Sept. 30) Earnings vs. expectations: DoorDash reported $0.55 EPS, missing Street estimates (variously reported around $0.67–$0.69). Total costs and expenses rose ~23% to $3.19B, pressuring margins. Reuters+1 Why
6 November 2025
·
D‑Wave Quantum (QBTS) Q3 2025: Revenue Doubles to $3.7M, Record $836M Cash, Bookings Accelerate — What It Means for the Stock Today

D‑Wave Quantum (QBTS) Q3 2025: Revenue Doubles to $3.7M, Record $836M Cash, Bookings Accelerate — What It Means for the Stock Today

D‑Wave Quantum Inc. (NYSE: QBTS) reported third‑quarter fiscal 2025 results before the open today, delivering 100% year‑over‑year revenue growth to $3.7 million and a sharp sequential uptick in customer bookings to $2.4 million. Shares were recently around $31 intraday, modestly higher following the print. The company also ended the quarter with a record $836.2 million cash balance, while GAAP net loss widened to $140.0 million—driven primarily by non‑cash warrant remeasurement charges. Business Wire Key numbers at a glance (Q3 FY25) Why GAAP loss widened while cash hit a record D‑Wave’s $140.0M GAAP net loss reflects $121.9M in non‑cash, non‑operating charges
6 November 2025
··
Warner Bros. Discovery (WBD) Q3 2025: Loss Widens as TV Slumps, Studio Soars on ‘Superman’; Zaslav Says Sale/Split Review “Active” — November 6, 2025

Warner Bros. Discovery (WBD) Q3 2025: Loss Widens as TV Slumps, Studio Soars on ‘Superman’; Zaslav Says Sale/Split Review “Active” — November 6, 2025

Warner Bros. Discovery, Inc. (Nasdaq: WBD) reported third‑quarter 2025 results before the bell on Thursday, detailing a sharper‑than‑expected loss as cord‑cutting weighed on TV networks, while the film studio outperformed on the back of “Superman” and other tentpoles. Management also reiterated that a strategic review—ranging from a full or partial sale to a previously announced two‑way split—remains underway, with no hard deadline. Reuters Top takeaways (Q3 FY2025) By segment (revenue): Streaming $2.63B (flat), Studios $3.32B (+24%), Global Linear Networks $3.88B (‑22%). Studio growth was driven by “Superman,” “Weapons,” and “The Conjuring: Last Rites.” MarketScreener+1 What management said — and what
6 November 2025
Arm Holdings (ARM) Beats Q2, Lifts Q3 Outlook on AI Momentum — What to Know Today (Nov. 6, 2025)

Arm Holdings (ARM) Beats Q2, Lifts Q3 Outlook on AI Momentum — What to Know Today (Nov. 6, 2025)

Why Arm is rallying today Arm delivered another “beat‑and‑raise” quarter as AI workloads continue to shift toward Arm’s power‑efficient compute. Revenue of $1.14B (+34% YoY) topped expectations, while non‑GAAP EPS of $0.39 cleared the Street. Management guided Q3 well above consensus, citing broad‑based strength across smartphones, automotive, IoT—and especially data centers, where hyperscalers are standardizing around Arm for performance‑per‑watt gains. Reuters Under the hood, royalties rose 21% to $620M—helped by higher‑value Armv9 designs and Arm’s Compute Subsystems (CSS)—and licensing surged 56% to $515M on the timing of several high‑value deals. Those metrics underscore Arm’s dual model (upfront IP licenses +
6 November 2025
···
e.l.f. Beauty (ELF) plunges as tariff hit and soft FY‑2026 outlook overshadow Rhode boost: what to know today (Nov. 6, 2025)

e.l.f. Beauty (ELF) plunges as tariff hit and soft FY‑2026 outlook overshadow Rhode boost: what to know today (Nov. 6, 2025)

What happened e.l.f. Beauty’s stock is tumbling today after the company’s fiscal Q2 print and FY‑2026 guidance underwhelmed investors. In last night’s release, management guided to $1.55–$1.57 billion in sales and $2.80–$2.85 adjusted EPS for FY‑2026, short of consensus (~$1.65B and ~$3.58). The outlook reflects a step‑down in profitability as U.S. import tariffs lift costs and growth in the core e.l.f. brand moderates versus last year’s blockbuster product cycle. Shares fell as much as ~26% after hours Wednesday and were still sharply lower in early Thursday trading. Elf Beauty Investor+1 By the numbers (Q2 FY‑2026) Guidance snapshot vs. last year
6 November 2025
··
ConocoPhillips (COP) beats Q3, hikes dividend 8%, lifts 2025 output; Willow budget raised to up to $9B — Nov. 6, 2025

ConocoPhillips (COP) beats Q3, hikes dividend 8%, lifts 2025 output; Willow budget raised to up to $9B — Nov. 6, 2025

ConocoPhillips (NYSE: COP) delivered a news‑packed earnings day: the U.S. independent beat third‑quarter profit expectations, raised its full‑year production guidance, increased its quarterly dividend by 8% to $0.84, and updated the cost outlook for its Willow project in Alaska to $8.5–$9.0 billion. Management also released preliminary 2026 guidance with lower planned capital and operating costs and flat‑to‑modest production growth. ConocoPhillips The quick take By the numbers (Q3 2025) What changed today — and why it matters Earnings beat and stronger 2025 outlook. ConocoPhillips outpaced expectations on adjusted profit thanks to higher production and lower operating costs. The company also lifted
6 November 2025
···
MMTec (MTC) soars 627% and then whipsaws pre‑market as Nasdaq delisting clock ticks — What to know today (Nov. 6, 2025)

MMTec (MTC) soars 627% and then whipsaws pre‑market as Nasdaq delisting clock ticks — What to know today (Nov. 6, 2025)

Micro‑cap MMTec, Inc. (NASDAQ: MTC) was the talk of the tape after a +626.97% explosion on Wednesday, Nov. 5, followed by a sharp pre‑market giveback early today. The fireworks come with a looming Nasdaq delisting determination tied to MTC’s minimum bid price deficiency and last year’s reverse split. Here’s the latest, what’s driving the move, and what to watch next. The Economic Times+2 What happened The delisting cloud driving the story Bottom line: The binary, event‑driven setup around a potential Nasdaq hearing is a key backdrop for the outsized moves you’re seeing this week. By the numbers (context for today)
6 November 2025
·
Comstock Resources (CRK) Jumps as Q3 Results, $430M Divestiture and Rising RS Rating Put Haynesville Gas in Focus — Nov. 6, 2025

Comstock Resources (CRK) Jumps as Q3 Results, $430M Divestiture and Rising RS Rating Put Haynesville Gas in Focus — Nov. 6, 2025

FRISCO, Texas — Nov. 6, 2025. Shares of Comstock Resources, Inc. (NYSE: CRK) traded higher today after a week packed with catalysts: stronger third‑quarter results, progress on a $430 million asset sale, and a fresh technical tailwind as the stock’s Relative Strength (RS) rating ticked up. Midday, CRK changed hands around $21.14, up roughly 5.5%, within a 52‑week range of $11.41–$31.17. Reuters What’s moving CRK today Technical momentum: Investor’s Business Daily highlighted CRK’s RS Rating rising to 85, a level technicians often view as signaling mounting relative strength. While IBD notes CRK isn’t at a formal “buy” point, the upgrade
6 November 2025
··
Oscar Health (OSCR) Q3 2025: ~$3.0B Revenue, EPS Beats, 2025 Guidance Reaffirmed; Balance Sheet Simplified via Note Exchange — Nov. 6, 2025

Oscar Health (OSCR) Q3 2025: ~$3.0B Revenue, EPS Beats, 2025 Guidance Reaffirmed; Balance Sheet Simplified via Note Exchange — Nov. 6, 2025

What happened in Q3 Oscar Health reported third‑quarter revenue of $2,985,984,000 (in thousands), up from $2,423,482,000 a year ago—about 23% YoY growth, driven largely by higher membership. The medical loss ratio (MLR) increased to 88.5% (from 84.6%), which the company tied to a $130M net risk‑adjustment transfer accrual reflecting higher average market morbidity; this was partly offset by $84M of favorable prior‑period development and $22M favorable intra‑year development. The SG&A expense ratio improved to 17.5% (from 19.0%), reflecting cost discipline and fixed‑cost leverage. Business Wire On the bottom line, Oscar posted a net loss of $137.5M (–$0.53/share) versus a $54.6M
6 November 2025
·
Uranium Boom or Bust? Denison Mines (DNN) Stock Soars on Nuclear Revival – Full 2025 Analysis

Denison Mines (DNN) Q3 2025 Earnings Today: What to Watch as Wheeler River Faces Judicial Review

TORONTO — November 6, 2025 — Denison Mines Corp. (NYSE American: DNN; TSX: DML) is slated to report third‑quarter 2025 results today, capping a news‑packed week that includes a legal challenge tied to its flagship Wheeler River uranium project in Saskatchewan. Here’s everything investors need to know today—from the earnings setup and key catalysts to how the stock is trading. At a glance Earnings: setup and expectations What to listen for on the call The week’s other headline: judicial review filed On Nov. 4, Denison said it was served with a judicial review application from Peter Ballantyne Cree Nation that challenges the province’s EA approval for Wheeler River and
6 November 2025
··
Celsius Holdings (CELH) Q3 2025: Revenue Jumps 173% to $725.1M; GAAP Loss on Distribution Charges as PepsiCo Partnership Deepens

Celsius Holdings (CELH) Q3 2025: Revenue Jumps 173% to $725.1M; GAAP Loss on Distribution Charges as PepsiCo Partnership Deepens

At a glance (Q3 2025) Earnings headline: Big top‑line, accounting headwinds on the bottom line Celsius Holdings reported $725.1 million in Q3 sales, up 173% year over year, as the company’s broadened energy portfolio and expanded distribution powered growth. GAAP results swung to a $(0.27) diluted loss per share, primarily due to $246.7 million in distributor termination costs tied to moving Alani Nu into the PepsiCo system—costs that PepsiCo will fund in cash but which must be expensed up‑front under GAAP (with reimbursements amortized over the life of the agreement). On a non‑GAAP basis, adjusted EPS was $0.42. Business Wire
6 November 2025
····
Palantir Stock Skyrockets 150% – Inside the AI Defense Giant’s Epic 2025 Rally

Palantir (PLTR) adds two AI deals today—Stagwell marketing platform and Spain’s Valoriza—after blowout Q3: stock, guidance and what to watch (Nov. 6, 2025)

Key takeaways What’s new on November 6 1) Stagwell partnership: AI platform for marketers Palantir and Stagwell unveiled a joint product effort that pairs Palantir Foundry with Stagwell’s Code and Theoryorchestration layer and The Marketing Cloud data to give large brands a centralized, privacy-aware hub for campaign planning, audience alignment, and AI agents that automate complex marketing workflows. Early MVP adoption is underway via Stagwell’s media agency Assembly, with a broader opt‑in rollout planned. Stagwell CEO Mark Penn said the opportunity could scale to “hundreds of millions of dollars” over time, while Palantir CEO Alex Karp said the collaboration should make marketing “more dynamic.” PR Newswire Why it matters: It’s another proof
6 November 2025
··
Ford (F) Stock Surges on Earnings – Rally Faces EV & Recall Challenges

Ford (F) News Today — Nov. 6, 2025: Louisville plant pauses after UPS crash, Maverick 300T turns heads at SEMA, Farley questions Apple CarPlay Ultra; shares hover near $13

Ford Motor Company (NYSE: F) enters Thursday, November 6, 2025, with a full slate of developments: a safety‑driven production pause and planned restart in Louisville following a nearby UPS air crash, fresh performance hardware on display at SEMA, new global powertrain moves for Ranger/Everest, and continuing debate over Big Tech’s role in the dash. Below is your concise, investor‑focused roundup with context and what to watch next. Key takeaways (today) 1) Louisville: safety pause, then prep to restart After Tuesday’s UPS Flight 2976 crash near the airport and Ford’s LAP, Ford confirmed LAP operations were paused, employees were evacuated amid
6 November 2025
Moderna (MRNA) Beats Q3 on Sales of New COVID Shot, Trims 2025 Outlook; Stock Whipsaws — Nov. 6, 2025

Moderna (MRNA) Beats Q3 on Sales of New COVID Shot, Trims 2025 Outlook; Stock Whipsaws — Nov. 6, 2025

Moderna, Inc. (NASDAQ: MRNA) posted third‑quarter 2025 revenue of ~$1.02 billion and a GAAP loss of $0.51 per share, topping Wall Street estimates as sales of its updated COVID‑19 vaccine outperformed. The company narrowed its full‑year revenue range to $1.6–$2.0 billion, cut operating‑expense guidance, and raised its year‑end cash outlook. Shares popped in pre‑market trading before wobbling intraday. SEC+1 What happened Moderna’s Q3 print outpaced expectations on both the top and bottom lines, led by stronger‑than‑modeled sales of its updated COVID‑19 shot (marketed this season as mNEXSPIKE/Spikevax 2025–26). Management simultaneously tightened the full‑year revenue band and lowered operating‑expense plans, signaling
6 November 2025
··
Opendoor’s Meteoric 1600% Rally – Can the Real Estate Disruptor Keep Soaring or Will It Stumble Next?

Opendoor (OPEN) Q3 2025 Earnings Today: Robinhood Livestream Debut, What to Watch [Nov 6, 2025]

Nov 6, 2025 — Markets & Real Estate Technology Summary: Opendoor Technologies Inc. (NASDAQ: OPEN) reports Q3 2025 after today’s close and will replace its traditional call with a “Financial Open House” livestream—broadcast on Robinhood and the company’s IR site—followed by an investor Q&A. Here’s what’s happening today, why it matters, and the key metrics to watch when results drop. Opendoor Investor+2Opendoor Investor+2 Key facts at a glance (Nov 6, 2025) What’s new today (Nov 6) Context that’s driving today’s setup 1) A new leadership team—and new expectations Opendoor installed Kaz Nejatian as CEO in September and reinstated co‑founders Keith Rabois (chairman) and Eric Wu to the board. The changes
6 November 2025
··
1 … 1,352 1,353 1,354 1,355 1,356 … 1,631

Stock Market Today

Nu stock jumps to $17.40 as traders eye Nubank’s next catalyst

Nu stock jumps to $17.40 as traders eye Nubank’s next catalyst

7 February 2026
Nu Holdings shares climbed 3.5% to $17.40 Friday, reversing Thursday’s loss, as the Dow closed above 50,000 for the first time. Nu recently received conditional approval from U.S. regulators to form a national bank, but still needs further sign-offs before launching. The company manages $38.8 billion in deposits and reports earnings Feb. 25.
MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Go toTop